首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1542630

全球生物反应器和发酵槽市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Bioreactors and Fermenters Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球生物反应器和发酵槽市场需求预计将从2023年的40.9147亿美元达到2032年的近121.1587亿美元，2024-2032年研究期间的复合年增长率为12.82%。

生物反应器和发酵槽在受控条件下培养微生物或细胞以生产生物产品。生物反应器提供了一个可以有效生物反应的环境，促进发酵、细胞培养和组织工程过程。发酵槽是生物反应器的一种，透过管理温度、pH 值和氧气水平等变数来专门支持发酵过程，以优化微生物生长和产品产量。这两个系统在製药、生技和食品生产产业都至关重要。它们可以生产生物製药、酵素和生物燃料等产品。生物反应器和发酵槽技术的进步，包括自动化和製程控制的改进，提高了生产力和可扩展性，反映了它们在现代生物製造和研究应用中的关键作用。

市场动态

由于生物製药需求不断增长，生物反应器和发酵槽市场正在强劲成长，需要先进的生物反应器技术来进行大规模生产。慢性病盛行率的上升和对个人化医疗的关注推动了对生物製药的需求，从而增加了对满足严格生产要求的高效生物反应器系统的需求。生物反应器设计的技术进步，包括自动化、即时监控和製程控制的创新，正在创造重大机会。这些进步提高了製程效率，降低了营运成本，并提高了产品一致性，使生物反应器和发酵槽对各种应用更具吸引力。例如，整合先进的传感器和资料分析可以更精确地控制生物过程，从而提高产量并提高产品品质。

不断扩大的生物技术和製药行业正在推动市场成长。包括单株抗体和基因疗法在内的新生物製剂的开发需要能够支援复杂生产过程的复杂生物反应器系统。此外，细胞和基因治疗市场的成长为生物反应器应用提供了新的机会，因为这些疗法需要专门的设备进行细胞培养和扩增。生物反应器在食品和饮料行业中用于生产益生菌、酵素和发酵产品。消费者对天然和健康食品的偏好日益增加，推动了对生物技术製程的需求，从而推动了生物反应器市场的成长。新兴市场也透过投资生物製造基础设施和采用先进的生物反应器技术来支持当地产业需求，从而促进市场成长。然而，先进生物反应器和发酵槽的初始资本投资和维护成本较高，可能会抑制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球生物反应器和发酵槽市场的每个细分市场进行了包容性评估。生物反应器和发酵槽产业的成长和趋势为本研究提供了整体方法。

市场区隔

生物反应器和发酵槽市场报告的这一部分提供了国家和区域层面的细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依产品类型

免洗生物反应器
多用途生物反应器

按流程

联准会批次
连续的
批次

按最终用户

生物製药公司
合约研究组织
学术及研究机构

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲生物反应器和发酵槽市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。生物反应器和发酵槽市场的主要参与者包括Applikon Biotechnology BV、Finesse Solutions Inc、Danaher Corporation、PBS Biotech Inc.、Eppendorf AG、Sartorius AG、GE Healthcare、Zeta Holding GmbH、Pierre Guerin Technologies、Solaris Biotechnology Srl、Merck KGaA、 Thermo Fisher Scientific Inc. 本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：生物反应器和发酵槽公司的竞争格局

生物反应器和发酵槽市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Applikon Biotechnology BV

公司概况
公司收入
产品
最新动态

Finesse Solutions Inc

公司概况
公司收入
产品
最新动态

Danaher Corporation

公司概况
公司收入
产品
最新动态

PBS Biotech Inc.

公司概况
公司收入
产品
最新动态

Eppendorf AG

公司概况
公司收入
产品
最新动态

Sartorius AG

公司概况
公司收入
产品
最新动态

GE Healthcare

公司概况
公司收入
产品
最新动态

Zeta Holding GmbH

公司概况
公司收入
产品
最新动态

Pierre Guerin Technologies

公司概况
公司收入
产品
最新动态

Solaris Biotechnology Srl

公司概况
公司收入
产品
最新动态

Merck KGaA

公司概况
公司收入
产品
最新动态

Thermo Fisher Scientific Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11214500

The global demand for Bioreactors and Fermenters Market is presumed to reach the market size of nearly USD 12115.87 Million by 2032 from USD 4091.47 Million in 2023 with a CAGR of 12.82% under the study period 2024-2032.

Bioreactors and fermenters cultivate microorganisms or cells to produce biological products under controlled conditions. Bioreactors provide an environment where biological reactions can occur efficiently, facilitating fermentation, cell culture, and tissue engineering processes. Fermenters, a type of bioreactor, specifically support fermentation processes by managing variables like temperature, pH, and oxygen levels to optimize microbial growth and product yield. Both systems are crucial in pharmaceuticals, biotechnology, and food production industries. They enable the production of biopharmaceuticals, enzymes, and biofuels, among other products. Bioreactor and fermenter technology advancement, including automation and process control improvements, enhances productivity and scalability, reflecting their critical role in modern biomanufacturing and research applications.

Market Dynamics

The bioreactors and fermenters market is witnessing robust growth fuelled by the rising demand for biopharmaceuticals, necessitating advanced bioreactor technologies for large-scale production. The rising prevalence of chronic diseases and the focus on personalized medicine fuel the need for biopharmaceuticals, thus boosting demand for efficient bioreactor systems that meet stringent production requirements. Technological advancements in bioreactor design, including innovations in automation, real-time monitoring, and process control, are creating significant opportunities. These advancements enhance process efficiency, reduce operational costs, and improve product consistency, making bioreactors and fermenters more attractive for various applications. For instance, integrating advanced sensors and data analytics enables more precise control of bioprocesses, facilitating higher yields and better-quality products.

The expanding biotechnology and pharmaceutical sectors are propelling market growth. The development of new biologics, including monoclonal antibodies and gene therapies, requires sophisticated bioreactor systems capable of supporting complex production processes. Additionally, the growth of the cell and gene therapy market presents new opportunities for bioreactor applications, as these therapies require specialized equipment for cell culture and expansion. Bioreactors are used in the food & beverage industry to produce probiotics, enzymes, and fermentation products. The increasing consumer preference for natural and health-oriented food products drives the demand for biotechnological processes, thereby fueling the growth of the bioreactor market. Emerging markets also contribute to market growth by investing in biomanufacturing infrastructure and adopting advanced bioreactor technologies to support local industry needs. However, the high initial capital investment and maintenance costs of advanced bioreactors and fermenters may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioreactors and Fermenters. The growth and trends of Bioreactors and Fermenters industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Bioreactors and Fermenters market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Single-use Bioreactors
Multiple-use Bioreactors

By Process

Fed batch
Continuous
Batch

By End User

Biopharmaceutical companies
CROs
Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Bioreactors and Fermenters market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioreactors and Fermenters market include Applikon Biotechnology B.V., Finesse Solutions Inc, Danaher Corporation, PBS Biotech Inc., Eppendorf AG, Sartorius AG, GE Healthcare, Zeta Holding GmbH, Pierre Guerin Technologies, Solaris Biotechnology Srl, Merck KGaA, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOREACTORS AND FERMENTERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Process
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Single-use Bioreactors Historic and Forecast Sales By Regions
5.4. Multiple-use Bioreactors Historic and Forecast Sales By Regions

6. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY PROCESS

6.1. Overview By Process
6.2. Historical and Forecast Data Analysis By Process
6.3. Fed batch Historic and Forecast Sales By Regions
6.4. Continuous Historic and Forecast Sales By Regions
6.5. Batch Historic and Forecast Sales By Regions

7. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Biopharmaceutical companies Historic and Forecast Sales By Regions
7.4. CROs Historic and Forecast Sales By Regions
7.5. Academic & Research Institutes Historic and Forecast Sales By Regions

8. GLOBAL BIOREACTORS AND FERMENTERS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIOREACTORS AND FERMENTERS COMPANIES

9.1. Bioreactors and Fermenters Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BIOREACTORS AND FERMENTERS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Applikon Biotechnology B.V.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Finesse Solutions Inc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Danaher Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. PBS Biotech Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Eppendorf AG
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Sartorius AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. GE Healthcare
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Zeta Holding GmbH
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Pierre Guerin Technologies
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Solaris Biotechnology Srl
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Merck KGaA
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Thermo Fisher Scientific Inc
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments